Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins

Mucosally Delivered Salmonella Typhi Expressing the Yersinia pestis F1 Antigen Elicits Mucosal and Systemic Immunity Early in Life and Primes the Neonatal Immune System for a Vigorous Anamnestic Response to Parenteral F1 Boost

(2014) K. Ramirez et al.   JOURNAL OF IMMUNOLOGY

Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

(2011) Elizabeth B. Norton et al.   Clinical and Vaccine Immunology

Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates

(2011) J.K. Simon et al.   CLINICAL IMMUNOLOGY

Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine

(2011) Mark S. Riddle et al.   VACCINE

Conformational Changes in IpaD fromShigella flexneriupon Binding Bile Salts Provide Insight into the Second Step of Type III Secretion

(2010) Nicholas E. Dickenson et al.   BIOCHEMISTRY

Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas

(2010) Margaret Kosek et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Emergence of a Novel Shigella flexneri Serotype 4s Strain That Evolved from a Serotype X Variant in China

(2010) S. Qiu et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Formulation and Immunogenicity of a Potential Multivalent Type III Secretion System-Based Protein Vaccine

(2010) Aaron P. Markham et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Antimicrobial Resistance Trends of Shigella Serotypes in New York City, 2006–2009

(2010) Melissa R. Wong et al.   Microbial Drug Resistance

Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers

(2010) D. Tribble et al.   VACCINE

Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh

(2010) Kazi Mizanur Rahman et al.   VACCINE

Magnitude of drug resistant shigellosis: A report from bangalore

(2009) M Baijayanti et al.   Indian Journal of Medical Microbiology

Liposomes Recruit IpaC to the Shigella flexneri Type III Secretion Apparatus Needle as a Final Step in Secretion Induction

(2009) C. R. Epler et al.   INFECTION AND IMMUNITY

Emergence of a New Multidrug-Resistant Serotype X Variant in an Epidemic Clone of Shigella flexneri

(2009) C. Ye et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection

(2009) K Ramirez et al.   Mucosal Immunology

Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity

(2009) S. Barnoy et al.   VACCINE